VANCOUVER, June 22 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, May 19 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, Sept. 25 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company...
VANCOUVER, June 26 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, May 24 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, March 31 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, March 17 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, March 5 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company today...
VANCOUVER, Nov. 14 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. (TSX: DDD; OTCBB: DRUG; BBSE: DRP) today announced that it has entered an agreement with an unaffiliated party for the...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.97 | -3.67743139817 | 53.57 | 58 | 49.26 | 920 | 55.20830858 | CS |
4 | -13.15 | -20.3088803089 | 64.75 | 67.53 | 49.26 | 1772 | 54.49906235 | CS |
12 | 49.96 | 3046.34146341 | 1.64 | 108 | 1.64 | 17255 | 52.75867856 | CS |
26 | 50.22 | 3639.13043478 | 1.38 | 108 | 1.3 | 8269 | 50.66608531 | CS |
52 | 49.48 | 2333.96226415 | 2.12 | 108 | 1.29 | 4519 | 46.13478024 | CS |
156 | 30.45 | 143.971631206 | 21.15 | 108 | 1.29 | 11030 | 15.20414058 | CS |
260 | 21.6 | 72 | 30 | 108 | 1.29 | 11225 | 20.08371263 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales